Drug Shortage Report for TARO-TICAGRELOR
Report ID | 178087 |
Drug Identification Number | 02492571 |
Brand name | TARO-TICAGRELOR |
Common or Proper name | TICAGRELOR |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TICAGRELOR |
Strength(s) | 60MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 BLISTER |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-08 |
Estimated end date | 2023-02-24 |
Actual end date | 2022-12-21 |
Shortage status | Resolved |
Updated date | 2022-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-22 | French | Compare |
v4 | 2022-12-22 | English | Compare |
v3 | 2022-12-12 | French | Compare |
v2 | 2022-12-12 | English | Compare |
v1 | 2022-12-12 | English | Compare |
Showing 1 to 5 of 5